Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term antibody persistence and immune memory after adolescent Twinrix vaccination
2015-001517-27Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of hepatitis b vaccine recombinant and hepatitis A + hepatitis B vaccine in hepatitis A (HAV) and hepatitis B (HBV) (2 cohorts), sponsored by GSK. Primary endpoints: Anti-HAV antibody titres and Anti-HBs antibody titres.
02
Drugs
hepatitis b vaccine recombinanthepatitis A + hepatitis B vaccine
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2015-001517-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001517-27.